The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.

Global sensation Nick Jonas has always been open about his health journey, and recently, the singer reflected on being ...

The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 15 Day ...

Nick Jonas is finally opening up about his rare health condition as he announces his paid partnership with Dexcom.The ...

Nick Jonas reflected on his Type 1 diabetes diagnosis at 13, and how it felt like shutting the door on his dreams. He penned ...

FDA clears Dexcom G7 15-Day CGM for adults, offering 15.5 days of wear and a MARD of 8.0% for improved diabetes management.

DexCom (NasdaqGS:DXCM) recently experienced a 14% price increase over the past week. This uptick coincides with the company's announcement of FDA clearance for the Dexcom G7 Continuous Glucose ...

Nick Jonas has given a surprising update on his diabetes journey.The Jonas Brothers member was diagnosed with type 1 diabetes ...

She is also a Certified Stress Management Coach. The US Food and Drug Administration has cleared the Dexcom G7 15-Day Continuous Glucose Monitor (CGM) for people older than 18 with diabetes.

“The approval of Dexcom G7 15 Day marks another major innovation for Dexcom,” said Jake Leach, executive vice president and chief operating officer at Dexcom. “By listening to the needs of ...

announced today the FDA has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes in the United States. With an overall MARD of 8.0% ...